Fauzia Tabassum
Overview
Explore the profile of Fauzia Tabassum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akhtar M, Shaik Alavudeen S, Orayj K, Tabassum F, Salman Almujri S, Alshaiban A, et al.
Pak J Pharm Sci
. 2025 Mar;
38(1):15-24.
PMID: 40089926
Risk assessment for cardiovascular diseases (CVD) is fundamental to prevention, enabling early intervention when risks are recognized. This cross-sectional study focuses on evaluating the knowledge, attitude, practices and perceived barriers...
2.
Rani A, Zia-Ul-Sabah , Tabassum F, Sharma A
Eur J Neurosci
. 2024 Jan;
59(7):1833-1847.
PMID: 38217338
Neurodegenerative diseases (NDs) are a significant global health concern, primarily affecting middle and older populations. Recently, there has been growing interest in herbal therapeutics as a potential approach to address...
3.
Akhtar M, Alavudeen S, Raza A, Imam M, Almalki Z, Tabassum F, et al.
Life Sci
. 2023 Nov;
334:122168.
PMID: 37945509
No abstract available.
4.
Akhtar M, Alavudeen S, Raza A, Imam M, Almalki Z, Tabassum F, et al.
Life Sci
. 2023 Sep;
332:122087.
PMID: 37714373
Diabetic Mellitus has been characterized as the most prevalent disease throughout the globe associated with the serious morbidity and mortality of vital organs. Cardiomyopathy is the major leading complication of...
5.
Farheen M, Akhter M, Chitme H, Akhter M, Tabassum F, Jaremko M, et al.
Pharmaceuticals (Basel)
. 2023 Jun;
16(2).
PMID: 37259356
The aim of the present study is to develop Doxorubicin-Erlotinib nanoparticles (Dox-Erlo NPs) and folate-armored Dox-Erlo-NP conjugates for targeting glioma cancer. Glioma is one of the most common progressive cancerous...
6.
Sharma A, Sharma A, Lal S, Kumar A, Yadav N, Tabassum F, et al.
Drug Discov Today
. 2023 Mar;
28(5):103558.
PMID: 36948384
A healthy life depends on the inseparable relationship between a host and the gut microbiota. A healthy gut microbiota regulates intestinal integrity, whereas an unbalanced gut microbiota contributes to junctional...
7.
Resveratrol-Loaded Chia Seed Oil-Based Nanogel as an Anti-Inflammatory in Adjuvant-Induced Arthritis
Afzal O, Altamimi A, Alamri M, Altharawi A, Alossaimi M, Akhtar M, et al.
Gels
. 2023 Feb;
9(2).
PMID: 36826301
Natural anti-inflammatory nutraceuticals may be useful in preventing rheumatoid arthritis from worsening. Resveratrol (RV) and chia seed oil, having antioxidant potential, can assist in avoiding oxidative stress-related disorders. This investigation...
8.
Sharma A, Mukherjee M, Kumar A, Sharma G, Tabassum F, Akhtar M, et al.
Life Sci
. 2022 Dec;
314:121322.
PMID: 36574941
Background: Redox biology balances free radical generation and scavenging systems, whereas an imbalanced cellular redox can hasten the onset of various diseases and be regarded as a Pandora's box of...
9.
Akhtar M, Hassan M, Siddiqui A, Alavudeen S, Afzal O, Altamimi A, et al.
Acta Cardiol
. 2022 Oct;
78(2):170-187.
PMID: 36222590
Inotropic agents are generally recommended to use in patients with acute decompensated heart failure (HF) with reduced ejection fraction (HFrEF) concurrent to end-organ dysfunction. However, due to certain pharmacological limitations...
10.
Akhtar M, Hassan Q, Afzal O, Altamimi A, Hassan M, Sharma A, et al.
Curr Mol Pharmacol
. 2022 Sep;
16(6):629-639.
PMID: 36121084
Objective: Cardiac ischemia-related myocardial damage has been considered a major reason for heart failure. We aimed to investigate the role of levosimendan (LEVO) in comparison to ramipril and sacubitril/valsartan (Sac/Val)...